AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2012

Mar 7, 2012

30870_dirs_2012-03-07_a18c136f-750d-4d98-bca7-efccc4e30460.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2012-03-05

Reporting Person: SMITH SANDFORD D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-05	Non-Qualified Stock Option (right to buy)	$1.05	A	40000	Acquired	2022-03-05	Common Stock (40000)	Direct

Footnotes

F1: This option shall vest and become exercisable as to 40,000 shares divided into equal monthly installments such that the option shall be 100% vested on March 5, 2015.